These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7780685)

  • 1. Inhibition of human group II phospholipase A2 by C-reactive protein in vitro.
    Vadas P; Stefanski E; Grouix B; Schouten BD; Pruzanski W
    J Lipid Mediat Cell Signal; 1995 Mar; 11(2):187-200. PubMed ID: 7780685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvements of fibronectin and lysophosphatidylcholine for selective binding of C-reactive protein.
    Mori S; Nakata Y; Endo H
    Cell Mol Biol; 1991; 37(4):421-31. PubMed ID: 1657391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
    J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2.
    Kinkaid AR; Othman R; Voysey J; Wilton DC
    Biochim Biophys Acta; 1998 Feb; 1390(2):173-85. PubMed ID: 9507109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phospholipases A1 and A2 in heart, liver, and blood during endotoxin shock.
    Liu MS; Kang GF; Ghosh S
    J Surg Res; 1988 Nov; 45(5):472-80. PubMed ID: 3054324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.
    Hite RD; Seeds MC; Jacinto RB; Balasubramanian R; Waite M; Bass D
    Am J Physiol; 1998 Oct; 275(4):L740-7. PubMed ID: 9755106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II phospholipases A2 are indirectly cytolytic in the presence of exogenous phospholipid.
    Vadas P
    Biochim Biophys Acta; 1997 Jun; 1346(2):193-7. PubMed ID: 9219902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.
    Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death.
    Nijmeijer R; Willemsen M; Meijer CJ; Visser CA; Verheijen RH; Gottlieb RA; Hack CE; Niessen HW
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2218-24. PubMed ID: 12805018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock.
    Vadas P; Stefanski E; Pruzanski W
    Agents Actions; 1986 Nov; 19(3-4):194-202. PubMed ID: 3825740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
    Koumanov K; Wolf C; Béreziat G
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):227-33. PubMed ID: 9337873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.
    Baker SF; Othman R; Wilton DC
    Biochemistry; 1998 Sep; 37(38):13203-11. PubMed ID: 9748327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2.
    Buckland AG; Wilton DC
    Biochim Biophys Acta; 1998 Apr; 1391(3):367-76. PubMed ID: 9555096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
    Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous, vesicle-based fluorimetric assays of 14- and 85-kDa phospholipases A2.
    Bayburt T; Yu BZ; Street I; Ghomashchi F; Laliberté F; Perrier H; Wang Z; Homan R; Jain MK; Gelb MH
    Anal Biochem; 1995 Nov; 232(1):7-23. PubMed ID: 8600835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W; Lambeau L; Lazdunsky M; Cho W; Kopilov J; Kuksis A
    Biochim Biophys Acta; 2005 Sep; 1736(1):38-50. PubMed ID: 16122976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome.
    Vadas P; Pruzanski W
    Circ Shock; 1993 Feb; 39(2):160-7. PubMed ID: 8490995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of C-reactive protein (CRP) on surfactant function.
    Li JJ; Sanders RL; McAdam KP; Hales CA; Thompson BT; Gelfand JA; Burke JF
    J Trauma; 1989 Dec; 29(12):1690-7. PubMed ID: 2593200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.
    Vadas P; Scott K; Smith G; Rajkovic I; Stefanski E; Schouten BD; Singh R; Pruzanski W
    Life Sci; 1992; 50(11):807-11. PubMed ID: 1740964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.
    Koumanov KS; Quinn PJ; Béréziat G; Wolf C
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):625-30. PubMed ID: 9841874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.